Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study - Wikidata - wikimedia - TriplyDB

Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study

Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study

http://www.wikidata.org/entity/Q24813050

about

Epidemiologic characteristics and risk factors for renal cell cancer Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms Renal tumors: diagnostic and prognostic biomarkers Inhibition of endogenous hydrogen sulfide production in clear-cell renal cell carcinoma cell lines and xenografts restricts their growth, survival and angiogenic potential.A multinodular goiter as the initial presentation of a renal cell carcinoma harbouring a novel VHL mutation.Coexistent loss of INI1 and BRG1 expression in a rhabdoid renal cell carcinoma (RCC): implications for a possible role of SWI/SNF complex in the pathogenesis of RCC.Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinoma.Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors Contemporary epidemiology of renal cell cancer The multifaceted von Hippel-Lindau tumour suppressor protein.Inhibition of the hypoxia-inducible factor pathway by a G-quadruplex binding small molecule.Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC).Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma.MicroRNA target site polymorphisms in the VHL-HIF1α pathway predict renal cell carcinoma risk.Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome Cigarette smoking, von Hippel-Lindau gene mutations and sporadic renal cell carcinoma Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma Expression of insulin-like growth factor family genes in clear cell renal cell carcinoma.Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors The von Hippel-Lindau protein sensitizes renal carcinoma cells to apoptotic stimuli through stabilization of BIM(EL).Potential role of gene-environment interactions in ion transport mechanisms in the etiology of renal cell cancer.Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma Impact of anti-angiogenic treatments on metastatic renal cell carcinoma.Does axitinib (AG-01376) have a future role in metastatic renal cell carcinoma and other malignancies?Crossing paths in Human Renal Cell Carcinoma (hRCC).Loss of PBRM1 expression is associated with renal cell carcinoma progression.von Hippel-Lindau-dependent patterns of RNA polymerase II hydroxylation in human renal clear cell carcinomas Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma.Promoter CpG island methylation in ion transport mechanisms and associated dietary intakes jointly influence the risk of clear-cell renal cell cancer.Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma Link between dysregulated hypoxia signaling and aberrant methylation in clear cell renal cell carcinoma?Renal cell carcinoma with smooth muscle stroma lacks chromosome 3p and VHL alterations.Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status.Non-coding RNAs predict recurrence-free survival of patients with hypoxic tumours.Polymorphisms in genes of the renin-angiotensin-aldosterone system and renal cell cancer risk: interplay with hypertension and intakes of sodium, potassium and fluid.VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma.Immune consequences of anti-angiogenic therapyin renal cell carcinoma.Sequencing of Von Hippel-Lindau (VHL) Gene from Genomic DNA for Mutation Detection in Italian Patients.

P2860

Q24604561-4D9B7FC5-F6F6-4BA3-9030-FBD455CAA470 Q26785930-9F85DCE2-0D6E-4D1D-8989-63B3898647D0 Q26860500-5C47058F-3C78-4F4F-879A-1101454739DE Q27304863-5767E864-FF3E-4137-8CB2-AFBA46327878 Q33261672-D6C08BE3-826B-43D2-AF9E-2BC9C2F9AB47 Q33583093-F01BCBFD-ABE6-4315-A26D-B4758B2895B7 Q33597062-CC3F6D02-4375-416C-98A9-AF70A420C7DD Q34055338-67A05CEF-4243-40E1-9721-4CDA0D3ACF9B Q34598015-8A7A3D58-805B-4AD7-A20F-DA66359E75B9 Q34660062-AB327A29-1226-40B6-9BBA-EF87813EA18E Q35027407-95C352F1-91A8-4C75-A13E-BE2ED5CDC923 Q35760920-5E6596FD-F24D-43FD-85FF-A729121BD053 Q36088193-256794DB-6466-4E99-B262-ED5DEA70F994 Q36179757-824BDDD2-624E-43EC-BAE9-076CF1A78D3D Q36182156-9461ABCB-92D5-4942-93C8-C62725434C21 Q36612157-D3505398-7C58-4787-8B38-05ED153B2ADD Q36856839-EF8469F9-50FC-4FC2-9C44-D942194B56BE Q37048923-1E16B2C5-DAD3-4EBB-A986-E6CE3D6F6D28 Q37069569-301FFEB9-84A8-4BA3-A4A1-89EDA963341C Q37240022-E9654E5A-62D1-4CC1-9234-C669CC3EA072 Q37298591-90E76663-8B97-410F-B519-5CEB045B6A03 Q37401553-44BEAA75-3335-42A8-9648-724847284CAD Q37642792-DD446328-F727-4993-8E46-F9DC75E67CA2 Q37799821-B11CB369-F922-425B-A2B2-68B9766144E0 Q38064316-D6C41B37-E20E-40EC-ADA2-06231A22E27B Q39285387-D24AA405-5A3C-4255-818F-957C8F729063 Q39639553-2A403537-D9FC-4084-A5AB-0E9AEAC50E86 Q39704965-0AB61323-D4CA-4050-9267-C6C0FE462DF4 Q40508189-CBCA10FD-CD0C-4F7F-8D8A-A752995CAB58 Q41919666-EDB0EAAE-BD38-4A24-8B35-A5499A0D1E2A Q42086368-5B23886E-3625-454A-B1AF-90D743FD4D26 Q44178608-D6B626D9-8E3F-4E1F-879E-C6803AB057FF Q46014175-88F3A1D8-3BB9-4B8B-B08B-317B983CA27A Q48276196-66CE529E-CB8C-4F29-A2F4-9C67AA80FADD Q50652059-F7622C41-9F2D-45A3-B1AD-1F427ACA17D1 Q54627123-75D9E1BF-C014-493F-834E-22BB425AAA0B Q54981236-0B0560AB-1C7C-415D-83AC-089FF0CE5ADD Q55032138-7BE764A9-065C-4C53-818B-ACEFA7339764

P2860

Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study

http://www.wikidata.org/entity/Q24813050

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Prevalence of von Hippel-Linda ...... m The Netherlands cohort study

@ast

Prevalence of von Hippel-Linda ...... m The Netherlands cohort study

@en

Prevalence of von Hippel-Linda ...... m The Netherlands cohort study

@nl

type

label

Prevalence of von Hippel-Linda ...... m The Netherlands cohort study

@ast

Prevalence of von Hippel-Linda ...... m The Netherlands cohort study

@en

Prevalence of von Hippel-Linda ...... m The Netherlands cohort study

@nl

prefLabel

Prevalence of von Hippel-Linda ...... m The Netherlands cohort study

@ast

Prevalence of von Hippel-Linda ...... m The Netherlands cohort study

@en

Prevalence of von Hippel-Linda ...... m The Netherlands cohort study

@nl

P1433

Q24813050-48855492-139B-4D02-9FED-947A28E1248F

P1476

Q24813050-30200E1B-E8E4-4242-89C7-2F77E46FF0B8

P2093

Q24813050-3F2FE812-88D0-49D7-B769-4D7F79C57BD3

Q24813050-41F96FC3-1F0B-46ED-90C4-415846D9B171

Q24813050-567903C4-B8EB-46D3-9C4A-652F80C37502

Q24813050-B81E3266-00D8-4234-81AD-361B5AA49E09

Q24813050-EF3B95B5-CB59-4270-A8D9-3F3E7969092B

Q24813050-F1A85760-6715-4B10-B14C-C07FFC948E3A

P2860

Q24813050-0296290F-D4AC-4ED4-A98B-1CDB7ECE3303

Q24813050-05E7606F-6A8B-40AA-ADF1-70FBD934F066

Q24813050-23DA8E85-6739-49D2-B488-68D1650A0983

Q24813050-2F33204F-CECA-4AB1-A9DE-DC1AD1FB6E66

Q24813050-31EB3460-39CD-41EA-A0B2-D25F032244E0

Q24813050-34DF20F3-A40B-4753-B410-A95908481370

Q24813050-42FBD1FD-1996-47CB-A73F-CB3E3CFF5895

Q24813050-696C66EF-67D0-4864-937A-FDCCDAC5CF47

Q24813050-6D8660E6-0291-40BB-AF89-FAAFFCA7D86F

Q24813050-85BA80A1-83AE-423D-84CC-D1E32AE7069C

P2888

Q24813050-BC7AB791-156E-4CD2-A81F-D1B4D54FAF39

P304

Q24813050-22D87713-902E-4CB3-95C9-95EEDC5936DA

P31

Q24813050-12653C7A-BC41-40D9-877E-6A698E6FE445

P3181

Q24813050-EFE8E7BB-2827-4C35-A7C4-A0D34C426273

P356

Q24813050-F37A43C7-68E5-4570-824C-6EE85924386A

P407

Q24813050-9C9F374C-3BCF-478D-B2E1-489976202CBD

P433

Q24813050-5EE4F835-213F-4155-8C67-E991D6E51295

P478

Q24813050-7EAF73E1-D16D-4785-8649-45FEB837E3DB

P50

Q24813050-1E109D9E-1714-4823-B8A5-3F076882033C

Q24813050-BDA0937C-5F7A-4545-98C3-521B30D05811

P577

Q24813050-84E75291-2CA9-48B2-AC30-3EFF81B0751A

P5875

Q24813050-C9D30A9F-CADA-48A3-AD2A-BFC71D504052

P6179

Q24813050-34977AAA-C2E1-40CA-BBF6-A955F828633F

P698

Q24813050-BF45DA20-9ABD-455E-949B-998CD433E1A8

P921

Q24813050-C0C12EB3-AFE5-4218-938A-9C58A3A5C142

P932

Q24813050-BC21C1C6-7C1A-40FE-AE4E-665DB763822C

P3181

P356

P1433

P1476

Prevalence of von Hippel-Linda ...... m The Netherlands cohort study

@en

P2093

Boukje A C van Dijk

http://www.w3.org/2001/XMLSchema#string

Christina A Hulsbergen-van de Kaa

http://www.w3.org/2001/XMLSchema#string

Egbert Oosterwijk

http://www.w3.org/2001/XMLSchema#string

Hanneke J M Gorissen

http://www.w3.org/2001/XMLSchema#string

Jack A Schalken

http://www.w3.org/2001/XMLSchema#string

Kjeld P van Houwelingen

http://www.w3.org/2001/XMLSchema#string

P2860

The von Hippel-Lindau tumor suppressor gene and kidney cancer

Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma

Identification of the von Hippel-Lindau disease tumor suppressor gene

Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC

Advances in the molecular basis of renal neoplasia.

Epidemiologic aspects of renal cell cancer.

Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.

Prognostic significance of morphologic parameters in renal cell carcinoma.

pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation

Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.

P2888

P304

57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

798424

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1471-2407-5-57

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Piet A van den Brandt

P577

2005-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7808856

http://www.w3.org/2001/XMLSchema#string

P6179

1030207483

http://www.w3.org/2001/XMLSchema#string

P698

15932632

http://www.w3.org/2001/XMLSchema#string

P921

P932

1177929

http://www.w3.org/2001/XMLSchema#string